Brevan Howard Capital Management LP Sarepta Therapeutics, Inc. Transaction History
Brevan Howard Capital Management LP
- $13.9 Billion
- Q4 2024
A detailed history of Brevan Howard Capital Management LP transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 4,985 shares of SRPT stock, worth $513,754. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,985
Previous 3,646
36.73%
Holding current value
$513,754
Previous $455,000
33.19%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding SRPT
# of Institutions
535Shares Held
87.4MCall Options Held
1.55MPut Options Held
1.35M-
Black Rock Inc. New York, NY10.3MShares$1.06 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$936 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA8.7MShares$896 Million0.21% of portfolio
-
Janus Henderson Group PLC London, X04.33MShares$446 Million0.28% of portfolio
-
State Street Corp Boston, MA4.07MShares$419 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $9.02B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...